Company intelligence / Profile preview

medac GmbH

Wedel, Schleswig-Holstein, Germanymedac-group.com ↗
Ownership
Private
Employees
~2000
Development stage
Commercial
01

Overview

medac GmbH is an established German pharmaceutical company with over five decades of experience. It specializes in oncology, urology, autoimmune diseases, and hematology. The company offers both generic and proprietary drugs—including EMA-approved Gliolan—and has developed innovative products such as biosimilars and cell therapies. Its clinical portfolio includes more than fifty oncology compounds in commercial use worldwide. Notably, it achieved orphan drug status for Treosulfan in the EU.

Therapeutic areas
OncologyImmunologyInfectious DiseasesHematology
Modalities
Small molecules (e.g., methotrexate, mitomycin C)Biopharmaceuticals (biosimilars, cell therapies)Diagnostics (serological and PCR-based tests)
Industry
Biotech
02

Drug pipeline

6 assets

asparaginase (medac GmbH)

Approved

5 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborates globally with distribution partners; CDMO partnerships are part of business model.Investor relationship with Medexus Pharmaceuticals noted by CB Insights.

Beyond the preview

Go deeper on medac GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on medac GmbH.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call